Related Articles
17p12 deletion in breast cancer predicts resistance to neoadjuvant chemotherapy
Prediction of high-risk patients by genome-wide copy number alterations from remaining cancer after neoadjuvant chemotherapy and surgery
Evaluation of ERα, PR and ERβ isoforms in neoadjuvant treated breast cancer
Neoadjuvant chemotherapy for local advanced breast cancer with stage IIIB
Alteration of hTERT full-length variant expression level showed different gene expression profiles and genomic copy number changes in breast cancer